Replies to post #431819 on NorthWest Biotherapeutics Inc (NWBO)

[newman2021]

yes extrooper, it seems the IDH wild or the Mesencymal patient subgroup which is defined as the GBM now sees cure from our DcVaxL as there are patients alive in the 20-25% range for OS 5yrs. Whereas the existing SOCs give them 0% survival for 5yrs. Can you believe it!!!!!